ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,343Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 625

$823K Total Retail Price of All Prescriptions

Rank: 55 out of 625

678 Patients Receiving at Least One Drug in Part D
47%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

16% of this provider’s 678 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 10,417 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
AMLODIPINE BESYLATE 1,299 681 1 1
LISINOPRIL 943 505 2 5
PRAVASTATIN SODIUM 814 406 3 8
FUROSEMIDE 743 416 4 7
METOPROLOL TARTRATE 678 427 5 11
POTASSIUM CHLORIDE 619 369 6 19
RANITIDINE HCL 604 307 7 25
HYDROCODONE-ACETAMINOPHEN 547 388 S3 8 4
TRIAMTERENE-HCTZ 544 269 9 53
LEVOTHYROXINE SODIUM 493 286 10 3
ATORVASTATIN CALCIUM 451 273 11 9
GLIPIZIDE XL 447 266 10 12 83
OMEPRAZOLE 377 148 13 6
SIMVASTATIN 350 172 14 2
MELOXICAM 332 192 15 31
LOVASTATIN 326 154 16 58
METFORMIN HCL ER 289 102 17 41
SERTRALINE HCL 277 161 18 26
METFORMIN HCL 273 80 19 10
ENALAPRIL MALEATE 256 165 20 81
IBUPROFEN 211 67 21 114
CYCLOBENZAPRINE HCL 197 56 R 22 65
ALLOPURINOL 188 139 23 29
CARVEDILOL 188 80 23 23
LIPITOR 187 103 25 75
ZOLPIDEM TARTRATE 186 86 26 13
LANTUS 180 76 27 54
PROAIR HFA 177 68 28 57
HYDROCHLOROTHIAZIDE 173 78 29 12
TRAMADOL HCL 170 78 30 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 162 75 31 27
WARFARIN SODIUM 158 79 32 20
METOPROLOL SUCCINATE 156 87 33 15
GLIPIZIDE ER 147 72 34 68
KLOR-CON M20 145 70 35 47
NIFEDIPINE ER 141 111 36 111
GABAPENTIN 136 54 37 14
INSULIN SYRINGE 135 67 38 77
ADVAIR DISKUS 129 51 39 63
CLONIDINE HCL 126 40 40 50
TERAZOSIN HCL 125 95 41 149
DIOVAN HCT 121 97 42 52
GEMFIBROZIL 119 37 43 127
OXYBUTYNIN CHLORIDE 117 68 44 177
HYDRALAZINE HCL 107 67 45 80
GLYBURIDE-METFORMIN HCL 106 59 R 46 125
VERAPAMIL ER 106 83 46 103
ATENOLOL 105 63 48 22
CLOPIDOGREL 102 59 49 30
KLOR-CON M10 100 44 50 137
MONOJECT INSULIN SYRINGE 95 57 51 271
PHENYTOIN SODIUM EXTENDED 95 24 51 119
LANTUS SOLOSTAR 94 18 53 85
PLAVIX 92 48 54 43
LYRICA 92 36 54 71
VENTOLIN HFA 86 42 56 93
CHLORTHALIDONE 86 66 56 109
NOVOLOG 83 25 58 112
DIOVAN 83 66 58 28
COMBIVENT 82 30 60 126
NOVOLIN 70-30 78 24 61 154
ISOSORBIDE MONONITRATE ER 75 53 62 49
SPIRIVA 73 14 63 70
FLUOXETINE HCL 73 43 63 62
ALENDRONATE SODIUM 70 61 65 34
DONEPEZIL HCL 68 59 66 33
SPIRONOLACTONE 68 30 66 64
TRIAMTERENE-HYDROCHLOROTHIAZID 66 48 68 174
QUINAPRIL HCL 65 24 69 136
FLUTICASONE PROPIONATE 63 23 70 32
ACTOS 63 12 70 102
TRIAMCINOLONE ACETONIDE 62 26 72 168
LOSARTAN POTASSIUM 62 42 72 18
NAPROXEN 61 11 74 104
JANUVIA 60 13 75 74
TAMSULOSIN HCL 60 43 75 36
AZITHROMYCIN 58 28 77 40
NOVOLOG MIX 70-30 57 19 78 187
DIGOXIN 56 30 79 55
GLIMEPIRIDE 55 33 80 42
NITROSTAT 54 32 81 202
LOSARTAN-HYDROCHLOROTHIAZIDE 54 25 81 38
AMLODIPINE BESYLATE-BENAZEPRIL 51 12 83 48
AGGRENOX 51 48 83 189
AMITRIPTYLINE HCL 50 0 R 85 61
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.